Catalog No.
RHC93102
Species reactivity
Human
Host species
Mouse
Isotype
IgG1, lambda
Clonality
Monoclonal
Target
Parathyroid hormone-like protein, PTHrP, PTH-rP, Parathyroid hormone-related protein, PTHrP[107-139], PLP, PTHRP, PTHLH
Concentration
1.8 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P12272
Applications
ELISA
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
SAA0327
Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis., PMID:40309441
Selective modulation of the bone remodeling regulatory system through orthodontic tooth movement-a review., PMID:40115506
Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report., PMID:39924477
Successful Treatment of Methotrexate-associated Lymphoproliferative Disorder with the Pola-R-CHP Regimen., PMID:39757000
Anti-PTHrP blockade limits CD8+ T-cell exhaustion in anti-cancer immunotherapy., PMID:39554058
Latest on Anabolic Agents for Osteoporosis Treatment., PMID:39448133
Receptor activity-modifying protein modulation of parathyroid hormone-1 receptor function and signaling., PMID:39376604
Shoring Up Osteoporosis Management: A Fresh Start?, PMID:39142871
Clinical effects of teriparatide, abaloparatide, and romosozumab in postmenopausal osteoporosis., PMID:39009890
Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?, PMID:38938063
Connexin hemichannels drive lactation-induced osteocyte acidification and perilacunar-canalicular remodeling., PMID:38935505
The use of anabolic agents in the treatment of osteoporosis: a clinical update., PMID:38752851
Cardiovascular Safety of Romosozumab vs PTH Analogues for Osteoporosis Treatment: A Propensity-Score-Matched Cohort Study., PMID:38482603
The pathophysiology of hypophosphatemia., PMID:38087658
Exploring dual effects of dinutuximab beta on cell death and proliferation of insulinoma., PMID:37802653
PTHrP Regulates Fatty Acid Metabolism via Novel lncRNA in Breast Cancer Initiation and Progression Models., PMID:37568579
Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome., PMID:37045779
Markers for internal neoplasia in the horse., PMID:36495211
Antagonizing microRNA-19a/b augments PTH anabolic action and restores bone mass in osteoporosis in mice., PMID:36193848
Hypercalcemia in the setting of HTLV-1 infection and a normal PTHrP level., PMID:36137195
High Sensitivity Measurement of Parathyroid Hormone-Related Protein (PTHrP) in Plasma by LC-MS/MS., PMID:36127605
Immunoarray Measurements of Parathyroid Hormone-Related Peptides Combined with Other Biomarkers to Diagnose Aggressive Prostate Cancer., PMID:36074029
Involvement of Met receptor pathway in aggressive behavior of colorectal cancer cells induced by parathyroid hormone-related peptide., PMID:36051345
Parathyroid hormone-related protein (PTHrP) and malignancy., PMID:35953108
Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival., PMID:35761298
Parathyroid Hormone-Related Protein Inhibition Blocks Triple-Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal., PMID:35720668
Functional Properties of Two Distinct PTH1R Mutants Associated With Either Skeletal Defects or Pseudohypoparathyroidism., PMID:35720667
The role of osteoanabolic agents in the management of patients with osteoporosis., PMID:35635798
PTHrP induces STAT5 activation, secretory differentiation and accelerates mammary tumor development., PMID:35440032
Development of a PTHrP chemiluminescent immunoassay to assess humoral hypercalcemia of malignancy., PMID:35429486
Abaloparatide Improves Rotator Cuff Healing via Anabolic Effects on Bone Remodeling in a Chronic Rotator Cuff Tear Model of Rat With Osteoporosis: A Comparison With Denosumab., PMID:35404150
Anti-sclerostin antibodies and abaloparatide have additive effects when used as a countermeasure against disuse osteopenia in female rats., PMID:35398589
Anabolic Therapy for Osteoporosis., PMID:34313699
Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D., PMID:34231877
[Endoscopic ultrasound-guided fine-needle biopsy for diagnosis of pancreatic metastases producing parathyroid hormone-related protein]., PMID:33967133
A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression., PMID:33923316
Calcitriol-mediated hypercalcemia as an immune-related adverse event in a patient receiving nivolumab and ipilimumab for metastatic renal cell carcinoma, case report., PMID:33794867
PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability., PMID:33589425
Extracellular vesicles-released parathyroid hormone-related protein from Lewis lung carcinoma induces lipolysis and adipose tissue browning in cancer cachexia., PMID:33510128
Immune checkpoint inhibitor-associated hypercalcaemia., PMID:33374000
c-Met expression in renal cell carcinoma with bone metastases., PMID:33024658
High endogenous expression of parathyroid hormone-related protein (PTHrP) supports osteogenic differentiation in human dental follicle cells., PMID:32710187
Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis., PMID:32696118
Effects of alcohol and nicotine consumption on the development of apical periodontitis in rats: a correlative micro-computed tomographic, histological and immunohistochemical study., PMID:32516436
MiR-132/212 promotes the growth of precartilaginous stem cells (PCSCs) by regulating Ihh/PTHrP signaling pathway., PMID:32319512
Pharmacological Therapy of Osteoporosis: What's New?, PMID:32273690
Immunoexpression of bone resorption biomarkers in apical periodontitis in diabetics and normoglycaemics., PMID:32271943
Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma., PMID:32005896
-antibodysystem.jpg)
For research use only. Not for human or drug use.
